Product Information
ANNOVERA VAGINAL RING is a brand product labeled by Mayne Pharma, priced at $2315.2857 per EA under NDC 68308075201. Its NADAC has been published 104 times since Oct 9, 2024.
FDA first approved this application on Aug 10, 2018.
Strength
17.4; 103 mg/1; mg/1
Manufacturer
Mayne PharmaNDC
68308075201
Classification
Brand
Dosage Form
RING
Route
VAGINAL
Effective Date
9/23/2026
Active Ingredients
ETHINYL ESTRADIOL; SEGESTERONE ACETATEApproval Type
New Drug (NDA)
FDA Application
NDA209627FDA Approved
8/10/2018
On Market Since
8/16/2024
Price Statistics
The NADAC for ANNOVERA VAGINAL RING has been published 104 times since Oct 9, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $2315.2857 per EA |
|---|---|
| All-time high | $2320.1273 (Jan 15, 2025) |
| All-time low | $2313.0494 (Dec 17, 2025) |
| 52-week high | $2318.4893 |
| 52-week low | $2313.0494 |
| Median price | $2317.3058 |
| Average price | $2317.1854 |
| Largest weekly change | +0.1% (Mar 18, 2026) |
| Weeks tracked | 104 |
| Tracking since | Oct 9, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the segesterone acetate and ethinyl estradiol market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Mayne Pharma manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
segesterone acetate and ethinyl estradiol market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Estrogen class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ANNOVERA VAGINAL RING?
The current National Average Drug Acquisition Cost (NADAC) for ANNOVERA VAGINAL RING, manufactured by Mayne Pharma, is $2315.2857 per EA (NDC 68308075201), effective Sep 30, 2026.
How has the price of ANNOVERA VAGINAL RING changed over time?
Over the history we have for it, the NADAC for ANNOVERA VAGINAL RING has held within roughly two percent of its current level. It has been tracked across 104 weekly CMS publications since Oct 9, 2024.
What are the highest and lowest recorded NADAC prices for ANNOVERA VAGINAL RING?
Since Oct 9, 2024, the NADAC for ANNOVERA VAGINAL RING has ranged from a low of $2313.0494 (Dec 17, 2025) to a high of $2320.1273 (Jan 15, 2025), with a median of $2317.3058 per EA.
Are there cheaper alternatives to ANNOVERA VAGINAL RING?
No other NADAC-published product currently shares the active ingredient and strength of ANNOVERA VAGINAL RING in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures ANNOVERA VAGINAL RING?
ANNOVERA VAGINAL RING (NDC 68308075201) is labeled by Mayne Pharma, and CMS classifies it as a brand product.